NAVIDEA BIOPHARMACEUTICALS, INC. - FORM 10-Q - EX-32.1 - CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE - May 10, 2017

Attached files

file filename
EX-32.2 - CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE - NAVIDEA BIOPHARMACEUTICALS, INC.navb_ex32-2.htm
EX-31.2 - CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF - NAVIDEA BIOPHARMACEUTICALS, INC.navb_ex31-2.htm
EX-31.1 - CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF - NAVIDEA BIOPHARMACEUTICALS, INC.navb_ex31-1.htm
EX-10.6 - LATKIN EMPLOYMENT AGREEMENT - NAVIDEA BIOPHARMACEUTICALS, INC.navb_ex10-6.htm
10-Q - FORM 10-Q - NAVIDEA BIOPHARMACEUTICALS, INC.navb_form10-q.htm
 
Exhibit 32.1
 
CERTIFICATION OF PERIODIC FINANCIAL REPORT PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002, 18 U.S.C. SECTION 1350
 
The undersigned hereby certifies that he is the duly appointed and acting Chief Executive Officer of Navidea Biopharmaceuticals, Inc. (the “Company”) and hereby further certifies as follows:
 
(1) The periodic report containing financial statements to which this certificate is an exhibit fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
(2) The information contained in the periodic report to which this certificate is an exhibit fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
In witness whereof, the undersigned has executed and delivered this certificate as of the date set forth opposite his signature below.
 
May 10, 2017
 
/s/ Michael M. Goldberg
 
 
Michael M. Goldberg, M.D.
 
 
President and Chief Executive Officer
 
 
(principal executive officer)
 
 

NAVIDEA BIOPHARMACEUTICALS, INC. Reports